Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy

Reyes, A., Rao, R., Wiechmann, L., Sun, L., Ugras, S., & Taback, B. (2025). Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.03.021
Authors:
Arith Reyes
Roshni Rao
Lisa Wiechmann
Luona Sun
Stacy Ugras
Bret Taback
Affiliated Authors:
Arith Reyes
Roshni Rao
Lisa Wiechmann
Luona Sun
Stacy Ugras
Bret Taback
Columbia Affiliation:
Author Keywords:
axillary recurrence
clinical node negative
neoadjuvant chemotherapy
residual occult nodal disease
sentinel lymph node biopsy
elink
Publication Type:
Article
Unique ID:
10.1016/j.clbc.2025.03.021
PMID:
40274481
DOI:
10.1016/j.clbc.2025.03.021
Journal:
Clinical Breast Cancer
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: